Biotech Companies Provide Updated Financial Outlooks for 2026

10x Genomics has raised its 2026 revenue outlook to $610M-$630M, while Globus Medical outlined its 2026 non-GAAP EPS at $4.95-$5.05 and reaffirmed its revenue forecast of $3.18B-$3.22B. Both biotech companies provided updated financial projections for the coming years.